Financials Life Science REIT plc

Equities

LABS

GB00BP5X4Q29

Residential REITs

Real-time Estimate Cboe Europe 10:00:57 2024-06-03 am EDT 5-day change 1st Jan Change
33.95 GBX +1.65% Intraday chart for Life Science REIT plc -1.68% -46.33%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 354.4 253 221.2 116.9 - -
Enterprise Value (EV) 1 354.4 207.4 314.8 247.3 263.5 273
P/E ratio 46 x -9.15 x -10.2 x 10.8 x 8.15 x 5.66 x
Yield - 5.53% 6.33% 6.24% 7.37% 8.68%
Capitalization / Revenue - 19.5 x 16 x 6.24 x 5.23 x 4.7 x
EV / Revenue - 16 x 22.8 x 13.2 x 11.8 x 11 x
EV / EBITDA - 93.6 x 36.7 x 19.6 x 16 x 14.7 x
EV / FCF - - -19.2 x -124 x 264 x 273 x
FCF Yield - - -5.22% -0.81% 0.38% 0.37%
Price to Book - - - - - -
Nbr of stocks (in thousands) 350,000 350,000 350,000 350,000 - -
Reference price 2 1.012 0.7230 0.6320 0.3340 0.3340 0.3340
Announcement Date 5/23/22 3/27/23 3/26/24 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 12.97 13.8 18.74 22.33 24.9
EBITDA 1 - 2.217 8.576 12.6 16.5 18.6
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 - -27.47 -21.85 10.8 14.4 20.5
Net income 1 7.741 -27.61 -21.71 10.8 14.4 20.5
Net margin - -212.92% -157.29% 57.64% 64.48% 82.34%
EPS 2 0.0220 -0.0790 -0.0620 0.0310 0.0410 0.0590
Free Cash Flow 1 - - -16.42 -2 1 1
FCF margin - - -118.98% -10.67% 4.48% 4.02%
FCF Conversion (EBITDA) - - - - 6.06% 5.38%
FCF Conversion (Net income) - - - - 6.94% 4.88%
Dividend per Share 2 - 0.0400 0.0400 0.0208 0.0246 0.0290
Announcement Date 5/23/22 3/27/23 3/26/24 - - -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 93.6 130 147 156
Net Cash position 1 - 45.6 - - - -
Leverage (Debt/EBITDA) - - 10.91 x 10.35 x 8.885 x 8.392 x
Free Cash Flow 1 - - -16.4 -2 1 1
ROE (net income / shareholders' equity) - - 2.22% - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - - 24 33 22 10
Capex / Sales - - 174.16% 176.13% 98.51% 40.17%
Announcement Date 5/23/22 3/27/23 3/26/24 - - -
1GBP in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.334 GBP
Average target price
0.6067 GBP
Spread / Average Target
+81.64%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LABS Stock
  4. Financials Life Science REIT plc